12:00 AM
Nov 21, 2005
 |  BioCentury  |  Emerging Company Profile

Ariana: Juggling 5 balls at once

Ariana Pharmaceuticals SA is hoping that its computational technology will allow companies to speed up lead optimization and reduce failures due to toxicity by addressing five parameters simultaneously instead of sequentially: activity, absorption, stability, specificity and toxicity. The company's Knowledge Extraction and Management (KEM) technology provides chemists with practical suggestions based on multivariable analyses.

KEM is an adaptation of computational technology developed by artificial intelligence researchers at the French National Center for Scientific Research (CNRS) to predict outcomes based on multivariable data. It is being used, for example, to predict "pre-fault" conditions...

Read the full 443 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >